Prevalence of Lower Urinary Tract Symptoms in People with Multiple Sclerosis: A Systematic Review and Meta-analysis
- PMID: 32410904
- PMCID: PMC7204365
- DOI: 10.7224/1537-2073.2019-030
Prevalence of Lower Urinary Tract Symptoms in People with Multiple Sclerosis: A Systematic Review and Meta-analysis
Abstract
Background: No published study, to our knowledge, has systematically reviewed the prevalence estimates of lower urinary tract symptoms (LUTSs) and LUTS types in the general multiple sclerosis (MS) population. Therefore, a systematic review and a meta-analysis were conducted to determine the totality of literature investigating the prevalence of LUTSs and LUTS types in the general MS population according to International Continence Society definitions.
Methods: Various electronic databases were searched between January 4, 2018, and February 12, 2018. This review included observational studies involving adults (18 years or older) with a confirmed diagnosis of MS recruited from the general MS population using self-report and/or objective outcome measures for LUTSs.
Results: Twelve studies were included in the meta-analysis. The results showed that LUTSs were prevalent in people with MS, with a pooled prevalence of 68.41% using self-report and 63.95% using the objective measure of urodynamics. When considering LUTS types, urinary frequency was the predominant symptom, with a pooled prevalence estimate of 73.45%, followed by urgency assessed using self-report measures at 63.87%. Detrusor overactivity was found to be the most prevalent urodynamic symptom, with a pooled prevalence estimate of 42.9%, followed by detrusor sphincter dyssynergia at 35.44%.
Conclusions: This systematic review revealed that LUTSs are highly prevalent in MS. There is a need for improvement in the conduct and reporting of prevalence studies of LUTSs in MS and for the use of validated self-report outcome measures to enable pooling of data in the future.
Keywords: Multiple sclerosis (MS); Neurogenic bladder; Overactive bladder; Urinary tract symptoms.
© 2020 Consortium of Multiple Sclerosis Centers.
Conflict of interest statement
Dr Coote has disclosed a relationship with Novartis (fees for non-CME/CE services received directly from a commercial interest [contractor to deliver telerehabilitation as part of patient support program]). The other authors declare no conflicts of interest.
Figures
Similar articles
-
Which clinical risk factors determine a pathological urodynamic evaluation in patients with multiple sclerosis? an analysis of 100 prospective cases.World J Urol. 2013 Feb;31(1):229-33. doi: 10.1007/s00345-011-0820-y. Epub 2012 Jan 7. World J Urol. 2013. PMID: 22227822
-
Understanding the elements of overactive bladder: questions raised by the EPIC study.BJU Int. 2008 Jun;101(11):1381-7. doi: 10.1111/j.1464-410X.2008.07573.x. Epub 2008 Mar 10. BJU Int. 2008. PMID: 18336602
-
Erectile Dysfunction and Lower Urinary Tract Symptoms.Eur Urol Focus. 2017 Oct;3(4-5):352-363. doi: 10.1016/j.euf.2017.11.004. Epub 2017 Nov 27. Eur Urol Focus. 2017. PMID: 29191671 Review.
-
Is There a Relationship Between Overactive Bladder and Sexual Dysfunction in Women With Multiple Sclerosis?J Sex Med. 2022 May;19(5):729-737. doi: 10.1016/j.jsxm.2022.02.019. Epub 2022 Apr 1. J Sex Med. 2022. PMID: 35370100
-
Sacral neuromodulation: an effective treatment for lower urinary tract symptoms in multiple sclerosis.Int Urogynecol J. 2016 Mar;27(3):347-54. doi: 10.1007/s00192-015-2771-0. Epub 2015 Jul 9. Int Urogynecol J. 2016. PMID: 26156206 Review.
Cited by
-
Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination.Biomedicines. 2022 Feb 24;10(3):539. doi: 10.3390/biomedicines10030539. Biomedicines. 2022. PMID: 35327341 Free PMC article. Review.
-
Lower Urinary Tract Dysfunction in Pediatric Patients with Multiple Sclerosis: Diagnostic and Management Concerns.Children (Basel). 2024 May 16;11(5):601. doi: 10.3390/children11050601. Children (Basel). 2024. PMID: 38790596 Free PMC article.
-
The Impact of Urodynamic Findings on Fatigue and Depression in People with Multiple Sclerosis.Biomedicines. 2025 Mar 1;13(3):601. doi: 10.3390/biomedicines13030601. Biomedicines. 2025. PMID: 40149578 Free PMC article.
-
Efficacy of peripheral electrical nerve stimulation on improvements of urodynamics and voiding diary in patients with neurogenic lower urinary tract dysfunction: a systematic review and meta-analysis.Int J Surg. 2023 May 1;109(5):1342-1349. doi: 10.1097/JS9.0000000000000168. Int J Surg. 2023. PMID: 37026834 Free PMC article.
-
Potentially preventable hospitalizations and use of preventive services among people with multiple sclerosis: Large cohort study, USA.Mult Scler Relat Disord. 2022 Dec;68:104105. doi: 10.1016/j.msard.2022.104105. Epub 2022 Aug 11. Mult Scler Relat Disord. 2022. PMID: 36031692 Free PMC article.
References
-
- Thompson AJ, Toosy AT, Ciccarelli O. Pharmacological management of symptoms in multiple sclerosis: current approaches and future directions. Lancet Neurol. 2010;9:1182–1199. - PubMed
-
- Koldewijn EL, Hommes OR, Lemmens WA, Debruyne FM, van Kerrebroeck PE. Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis. J Urol. 1995;154:169–173. - PubMed
-
- Awad SA, Gajewski JB, Sogbein SK, Murray TJ, Field CA. Relationship between neurological and urological status in patients with multiple sclerosis. J Urol. 1984;132:499–502. - PubMed
-
- Abrams P, Cardozo L, Fall M et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol. 2002;187:116–126. - PubMed
LinkOut - more resources
Full Text Sources
Medical